re: Ann: Key Licence Provided by NewSouth Inn... My understanding is that's its a new patent and a new licence for treating cancer with their drug plus traditional chemo drugs.
Second two paragraphs state:
The discovery relates to the significant enhancement of the anti-cancer activity of certain well-established mainstream approved cancer drugs without simultaneously enhancing the associated side-effect profile occurring through the killing of normal-dividing cells; a factor that often limits the therapeutic value and utility of chemotherapy.
PharmAust is proceeding to undertake further work on this discovery as part of its development of its key anti-cancer product, PPL-1.
- Forums
- ASX - By Stock
- PAA
- Ann: Key Licence Provided by NewSouth Innovations
Ann: Key Licence Provided by NewSouth Innovations, page-6
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $80.22M |
Open | High | Low | Value | Volume |
16.5¢ | 17.5¢ | 16.5¢ | $276.1K | 1.636M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 379426 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 379426 | 0.165 |
9 | 219941 | 0.160 |
4 | 512800 | 0.155 |
13 | 2431665 | 0.150 |
2 | 21442 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 10000 | 1 |
0.175 | 211484 | 3 |
0.180 | 163500 | 3 |
0.185 | 375000 | 1 |
0.190 | 568698 | 5 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
PAA (ASX) Chart |